NCT06742021Recruiting
Application of DCE-MRI Based on 4D FreeBreathing in Predicting the Efficacy of Immune and Targeted Therapy in Lung Cancer
Source: ClinicalTrials.gov · Last updated 19 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study aims to address the challenge of predicting the efficacy of targeted and immunotherapy in lung cancer patients. By utilizing two DCE-MRI images-one before treatment and one after one treatment cycle-along with the patients' clinical and pathological information, we aim to achieve accurate prediction of the therapeutic efficacy of targeted and immunotherapy in lung cancer patients.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 195 (estimated)
- First submitted
- 15 Dec 2024
- Start date
- 11 Nov 2024
- Primary completion date
- 31 Jul 2026
- Lead sponsor
- Yunnan Cancer Hospital
- Diseases
- Lung cancer
- NCT number
- NCT06742021
What you commit to
- Study type: Interventional
- Planned participants: 195
- From 11 Nov 2024 to the primary completion date, 31 Jul 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Presence of MRI contraindications (e.g., metal implants, pacemaker implantation, etc.)
Other illness
- Allergy to gadolinium contrast agents
- Lesions difficult to delineate on images due to conditions such as atelectasis or diffuse lesions
Who the study is looking for
- Tumor size greater than 2 cm
- Age between 18 and 75 years
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Yunnan Cancer Hospital Coordinator of this site? Confirm its status | Kunming | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.